Community/Retail

Government affairs strategist Ron Lanton III, Esq, interviews Susan Pilch, vice president of policy and regulatory affairs for the National Community Pharmacists Association, about direct and indirect remuneration fees.

The Generic Pharmaceutical Association (GPhA) is pleased that Dr. Janet Woodcock, Director, Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER), highlighted the FDA pledge to clear the growing backlog of generic drugs awaiting FDA approval in today's Senate HELP hearing, Generic Drug User Fee Amendments: Accelerating Access to Generic Drugs.